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A case of Rubinstein-Taybi Syndrome with a CREB-
binding protein gene mutation
Rubinstein-Taybi syndrome (RTS) is a congenital disorder 
characterized by typical facial features, broad thumbs and toes, 
with mental retardation. Additionally, tumors, keloids and various 
congenital anomalies including congenital heart defects have been 
reported in RTS patients. In about 50% of the patients, mutations 
in the CREB binding protein (CREBBP) have been found, which 
are understood to be associated with cell growth and proliferation. 
Here, we describe a typical RTS patient with Arnold-Chiari 
malformation. A mutation in the CREBBP gene, c.4944_4945insC, 
was identified by mutational analysis.
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Introduction  
Rubinstein-Taybi syndrome (RTS) is a rare congenital disorder 
with distinctive facial appearance, broad thumbs, broad big toes 
and mental retardation. After the first report of the syndrome in 
19631), various coexisting conditions such as talon cusp, congenital 
heart defects, or skin anomalies have been reported2). In 1991, a 
first sporadic case of RTS with de novo reciprocal translocation 
t(2:16)(p13.3;p13.3) was reported3), and a year later, mutation in 
the gene encoding CREB-binding protein (CREBBP) localized in 
16p13.3 was identified to be the cause of RTS4). In approximately 
50% of patients, mutations in the CREBBP gene have been 
found5). Although mutations in another EP300 gene have been 
reported in a small number of patients (3%)6), half of the clinically 
diagnosed RTS patients are still genetically not confirmed, 
suggesting RTS is genetically heterogeneous. RTS might have been 
unrecognized or underreported in Korea, because only a few cases 
are so far on record. Furthermore, mutation studies have never 
been reported in Korean RTS patients.
Here, we report the first Korean case of genetically confirmed 
RTS associated with Arnold-Chiari malformation. 
Case report 
A four-year old boy first visited the outpatient clinic because 
of mental retardation and short stature. Born between a Korean 
father and a Japanese mother, the boy was delivered at term with 
a body weight of 3.68 kg without any perinatal problems. His 
initial crying was good, and his tone was normal. There was no 
other family member with mental retardation or neuromuscular 
disorder. He had received an operation on undescended testis 
when he was 8 months old. His developmental milestones were 
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globally delayed. He controlled his head at 5 months, rolled over 
at 9 months, walked with assist at 17 months, and walked alone at 
32 months. He could say only “mom” and “dad” at the age of 3. 
His height was 87.5 cm (<3 percentile), his weight 15.3 kg (10-25 p), 
and his head circumference 48.5 cm (3-50 p). Physical examination 
revealed a prominent forehead, highly arched eyebrows, down-
slanted palpebral fissures, a broad nasal bridge, a short upper lip 
and a pouting lower lip, and a grimacing smile (Fig. 1A). Broad 
thumbs and terminal broadening of the phalanges of the fingers 
were also present (Fig. 1B). No focal neurologic signs were present, 
and his neurologic examination was normal.
On ophthalmologic evaluation, an epiblepharon was revealed, 
but his fundus and disc were normal. Cardiac evaluation showed 
no abnormalities. His brain MRI study, taken when he was 3 
years old, revealed multifocal lesions with increased signal intensity 
in the subcortical white matter of both temporal, left parietal 
regions and periventricular deep white matter (Fig. 2A). Arnold-
Chiari malformation type I was also demonstrated (Fig. 2B). His 
chromosome study was normal with 46, XY and no abnormality 
was noted on tandem mass screening. His thyroid function test 
was normal. 
After obtaining informed consents from his parents, genetic 
analysis of his blood samples was performed. His genomic DNA 
was extracted from peripheral blood leukocytes using a Puregene 
DNA isolation kit (Gentra Systems Inc, Minneapolis, MN). 
Polymerase chain reaction was performed to amplify the entire 
coding and flanking regions of all exons of the CREBBP gene. 
Amplified products were sequenced bidirectionally using an ABI 
PRISM 3100 Genetic Analyzer (Applied Biosystems, Foster City, 
CA). Mutation analysis demonstrated a CREBBP gene mutation 
with a C insertion in exon 31, nt 4944-4945 (Fig. 3). 
From the neuropsychologic evaluation (KEDI-WISC) done at 
the age of 6, his overall Intelligence quotient (IQ) was measured 
as 49, below normal. He scored low in both Performance IQ 55 
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Fig. 1. Typcial facial features and broad thumbs of the patient. A) Note his small mouth, thin upper lip, micrognathia and 
antimongoloid slant of the palpebral fissures. B) Broad thumbs are noted in both hands. 
Fig. 2. Brain magnetic imaging of the patient. A) Sagittal T1-weighted image with gadolinium 
enhancement demonstrating mild downward displacement of cerebellar tonsil suggesting Arnold-
Chiari malformation type I. B) Axial T2-weighted image demonstrating subtle high signal intensity of 
periventricular and deep white matter of bilateral hemisphere.
A B
720     SH Kim, et al. • A case of Rubinstein-Taybi Syndrome with a CREB-binding protein gene mutation
and verbal IQ 53. He showed difficulties especially in fine-motor 
coordination and language skills. Special education with extra help 
was recommended for his school education. 
He received an operation on his epiblepharon when he was 6 
years old, and he visits the outpatient clinic on a regular basis, and 
the six-year old boy is now able to speak sentences of 2-3 words.
Discussion
RTS is a congenital disorder characterized by distinctive 
morphology. Typical facial features, big thumbs, big halluces, 
microcephaly, mental retardation, talon cusp and poor growth 
have been considered as the cardinal signs in RTS7). However 
in addition to these, many other anomalies in RTS have been 
reported including tumors, keloid tissues, congenital heart disease, 
genitourinary anomalies and joint abnormalities8). Premature 
thelarche9), and vascular ring10) have also been reported in RTS 
patients, although the relationship with the disease is not clear. Our 
patient also had typical features of facial dysmorphology, broad 
thumbs, mental retardation and cryptorchidism which is known 
to be associated with almost all males11). Additionally, Arnold-
Chiari malformation type I and white matter abnormalities 
were identified on his brain magnetic resonance imaging (MRI) 
without any relevant symptoms. Although corpus callosal agenesis 
had been reported in a Brazillian boy with RTS12), only few studies 
have described the associated central nervous system (CNS) 
malformations or brain MRI findings12), including corpus callosal 
agenesis in a Brazillian boy with RTS13). Further studies would 
be meaningful to see whether the CNS abnormalities are also 
commonly associated findings in RTS patients.  
CREBPP is a transcriptional coactivator, that participates 
in cAMP regulated gene expression. It acts by binding to 
phosphorylated CREB, a transcription factor14), and is also thought 
to work with other transcription factors such as GLI3 in the Sonic 
Hedgehog-Patched-Gli (SHH) pathway15). It is not yet clear how 
exactly this protein causes multiple malformations with a broad 
spectrum of clinical features. However, it is understood to be 
involved in cell growth, transformation and development, and its 
intrinsic histone acetyltransferase (HAT) activity is considered to 
play a major role in the process. 
The CREBPP mutation in our patient, a frame shift mutation 
leading to early termination of transcription, was recently 
reported in a large group of patients being evaluated for genotype-
phenotype correlations16). Although no significant correlations 
have been identified in previous studies17), this study suggests some 
correlation depending on the presence or type of the mutation: 
more frequent association with growth retardation in height and 
weight in patients with no CREBBP mutation, more frequent 
seizures in patients with CREBBP mutation, and a trend toward 
lower IQ and autistic features in patients with large deletions. Since 
genetic heterogeneity exist in RTS, careful genotype phenotype 
correlation would reveal separate groups that other specific genes 
might be involved. Therefore, further genetic tests may be deemed 
necessary, despite the fact that RTS could be diagnosed on clinical 
grounds. 
RTS is unique in that multiple congenital anomaly/intellec-
tual impairment is caused by a generalized dysregulation of 
gene expression18). Recognizing these multiple disabilities 
or malformations by early diagnosis is important, because 
multidisciplinary approach is required in the initial evaluation, 
treatment, and follow-up. We hope, from the present study, more 
RTS patients would be recognized in the early course of the 
disease, and that the genetic and clinical characteristics of RTS in 
the Korean population would be further clarified.
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